UNLIMITED (UNderstanding Lipid ImmunoMetabolIsm To trEat Disease) is a Horizon Europe - Marie Skłodowska-Curie Doctoral Network unraveling how lipid metabolism shapes immune cell function in health and disease. By confronting key challenges in lipid immunometabolism, the project explores how immune responses are regulated within tissue-specific microenvironments in conditions such as cancer, autoimmunity, and metabolic disorders.
The UNLIMITED network brings together a unique consortium of 15 beneficiaries, comprising 14 academic and 1 non-academic organizations. Through an interdisciplinary and highly innovative training programme, UNLIMITED trains Doctoral Candidates at the interface of immunology, metabolism, and advanced technologies. Combining single-cell and spatial approaches, multi-omics, and machine learning, and supported by secondments across leading academic and industrial partners, UNLIMITED prepares the next generation of researchers to drive breakthroughs in immunometabolism and precision medicine.
DC 14 - Microbial Metabolites as Immune Metabolic Switches: Rewiring Lipid Pathways to Shape T-Cell Function
Objectives
Aim of the project: This project aims to define how microbiome-derived metabolites control lipid metabolism in T cells and thereby shape immune function. The goal is to uncover metabolic pathways that can be targeted to modulate inflammation and immune responses.
Brief project description
The microbiome produces a vast repertoire of bioactive metabolites that influence host immunity. Yet, how microbial metabolites reshape lipid metabolism in T cells—and thereby regulate immune function—remains poorly defined.
This PhD project will systematically dissect how tissue- and microbiota-derived metabolites modulate fatty acid metabolism and effector function in T cells. The candidate will perform metabolite screening to identify compounds that alter T-cell metabolic fitness, differentiation, and immune activity. Identified hits will be mechanistically characterized using advanced immunometabolic profiling platforms.
A central focus lies on defining how microbial metabolites remodel lipid composition in effector T cells. State-of-the-art lipidomics will be integrated with single-cell metabolic technologies such as SCENITH (protein translation-based metabolic profiling) and Met-Flow (flow cytometry-based mapping of metabolic enzymes). These approaches enable pathway-resolved functional analysis at high resolution. Functional consequences will be assessed using CRISPR/Cas9 genome editing and will be validated in vivo.
Planned secondments:
Laura Bindila lab (University Medical Center of Mainz, Germany)
• Lipidomics and quantitative assays to identify lipid markers, disease mechanisms.
ActiTrexx lab, Dr. Helmut Jonuleit, (Mainz, Germany)
• Human T cells model to study disease mechanism/biomarker and validate therapeutic targets.
Further project information: https://www.unimedizin-mainz.de/unlimited-msca/projects/project-14.html
Benefits and Training
Eligibility Criteria
How to Apply
Documents to be submitted: Applicants must submit the following documents in English, compiled into one single PDF file (maximum size: 5 MB):
Important notes
Applications failing to include the requested documentation, that do not indicate the preferred research projects, or that do not meet the eligibility criteria WILL NOT be considered in this competition.
Gender Equality
The LIH is an equal opportunities employer. We are fully committed to removing any discriminatory barrier related to gender, and not only, in recruitment and career progression of our staff.
The LIH is attentive to gender representation among its leadership staff and aims to eliminate obstacles to recruitment and promotion of female leaders and their career development.
Applications including a letter detailing your motivation and a curriculum vitae should be sent through our website via the apply button below.
Please apply ONLINE formally through this web page.
Applications by email will not be considered.
All interested candidates irrespective of age, gender, race, disability, religion or ethnic background are encouraged to apply.